MathioudakisAG

Senior Lecturer in Respiratory Medicine @OfficialUoM Precision medicine in #COPD & #AECOPD, Clinical #Trials, #Guidelines, #EBM.

[MathioudakisAG @MathioudakisAG]

Thank you to the @HCPLiveNews editorial team and @ChelsieDerman for the opportunity to discuss this work.

💡In a FLAME post-hoc analysis we found 3-month withdrawal effects on COPD exacerbations after ICS or LAMA discontinuation.

🔗 https://t.co/PznxJuF85x

[ERS @EuroRespSoc]

Join us tomorrow for a special edition of ERS Vision Live featuring an expert panel chaired by Dr Eva Polverino and Prof. Sophia Schiza, providing an overview of the ERS Congress 2026 highlights.

📅 15 September (18:00–21:00 CEST)

Register your free place:

[ERS @EuroRespSoc]

📙 The ERS Bookshop is open until Tuesday!

Head to the World Village to browse and purchase the latest titles, including the recently-published ERS Monographs “Thoracic Ultrasound” and “Obstructive and Central Sleep Apnoea” 📚

@ERSpublications

[Med by Cell Press @MedCellPress]

Online Now: Withdrawal effects following treatment discontinuation: A blind spot in evidence-based medicine https://t.co/W5DRE75u8G

[ERS @EuroRespSoc]

Guidelines in brief: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia.

Access the full guideline (and additional content) via the ERS Respiratory Channel:https://t.co/p2Ad5j57re
Watch the video 👇

[Jonathan Gibb @gibb_jonathan]

"Deprioritising clinical academic salaries and pensions impacts an already diminishing consultant academic workforce and risks further irretrievable damage"
Letter to @educationgovuk @DHSCgovuk from Association of British Neurologists @BMA_Academics
https://t.co/zDeJBzTGO1

[Sachin Ananth @DrSachinAnanth]

Just published: our review showing the heterogeneity of outcomes reported in COPD clinical trials

This underlines the need for the @EuroRespSoc core outcome set for COPD pharmacotherapy trials, which I'm co-chairing with @MathioudakisAG and @LiesLahousse

https://t.co/2p9ztolTLk

[BMA Medical Academics @BMA_Academics]

Responding to @officestudents guidance from the Secretary of State for Education setting out funding for 2026-27 for universities that imposes cuts to funding for medical academics: https://t.co/CzWZTG1LZH

[James D Chalmers @ProfJDChalmers]

The European Respiratory Journal impact factor, released today, has increased to 23.8, its highest ever level outside of the COVID-19 pandemic.

We are incredibly proud of the high scientific impact of the ERJ @ERSpublications and very grateful to authors, reviewers, our outstanding publication office team and our outstanding editors.

Respiratory Journal IFs
Lancet Resp 34.7
ERJ 23.8
Journal of thoracic Oncology 23.3
AJRCCM 21.7
ERR 10.8
CHEST 9.8
Thorax 9.1

@EuroRespSoc @donsin4

[MathioudakisAG @MathioudakisAG]

That is a rigorous review!!

[Mohamed Hemida, MD @Hemida_MD]

I’m starting to think our manuscript at BMC Cardiovascular Journal didn’t go out for peer review. It went on a world tour. 😆

The editor didn’t just invite reviewers, they basically launched an open call to the entire cardiovascular community 😄

[MathioudakisAG @MathioudakisAG]

@WFostier @DrSachinAnanth @Freddy_Frost1 @BMA_Academics First, current funding structures (PhD fellowships, ACLs) are not set up as recognisable LTFT-style roles.

More importantly, this should not be about trying to “work around” the system. The system should recognise academic training, an established pathway, and offer a solution.

[MathioudakisAG @MathioudakisAG]

🚨 Clinical academics undertake years of additional research training — but this is not recognised in NHS consultant pay progression.

This creates a structural inconsistency → ~£72,000–£81,000 lifetime loss per research year during training.

📖https://t.co/GGhBIpum4T

[ERS @EuroRespSoc]

🚭 ERS urges other countries to follow the example of the United Kingdom (UK) after it announced a generational sales ban on tobacco.

Read more: https://t.co/PfQrkXUKUe

[Dr David J Armstrong @osteoporosisNI]

@victoriachgr Dr Victoria Chatzimavridou gave us a fascinating run through of her work on pelvic insufficiency fractures caused by radiotherapy. #BoneUp #ECTS26
I’m seeing more and more referrals like this to the clinic

[MathioudakisAG @MathioudakisAG]

@SaraOcana1 @DrSachinAnanth @Freddy_Frost1 @BMA_Academics Time spent in formal research training is not recognised in the same way, creating a structural inequity that is worth addressing.

[MathioudakisAG @MathioudakisAG]

@SaraOcana1 @DrSachinAnanth @Freddy_Frost1 @BMA_Academics By contrast, there are recognised exceptions, for example, doctors who train less than full time (for entirely valid wellbeing reasons) have their starting salary adjusted to align with full-time peers.

[MathioudakisAG @MathioudakisAG]

@cardiacpolymath @DrSachinAnanth @Freddy_Frost1 @BMA_Academics Thanks @cardiacpolymath — this is a simplified estimate (PhD at mid-training/ST5) to illustrate scale. The true impact varies by timing and career trajectory, and may often be higher. Pension effects are not included either.

[MathioudakisAG @MathioudakisAG]

Big thanks to @TheBMA @BMA_Academics @gibb_jonathan @DocStrain for sharing these findings with @wesstreeting and other stakeholders. We hope this inconsistency will now be reviewed and addressed.

[MathioudakisAG @MathioudakisAG]

🎯At a time when the UK is seeking to strengthen its life sciences sector and reverse declining numbers of medical academics, pay arrangements should support — not discourage — doctors from undertaking research training.